Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Valsartan versus lisinopril versus combination therapy for albuminuria in hypertensive chronic nephropathy
2004-005044-27Phase 2Active
- Sponsor
- Luis Miguel Ruilope Urioste
- Start
- Jan 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of valsartan, lisinopril and hydrochlorothiazide in chronic kidney disease (CKD), hypertension (HTN) and albuminuria (3 arms), sponsored by Luis Miguel Ruilope Urioste. Primary endpoints: Percent reduction in urinary albumin excretion rate at week 16 and Percent reduction in urinary albumin excretion rate at week 20. Started Jan 2006; status: active.
02
Drugs
valsartanlisinoprilhydrochlorothiazide
03
Conditions
chronic kidney disease (CKD)hypertension (HTN)albuminuria
Beyond the preview
Go deeper on 2004-005044-27.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-005044-27.